Business Lilly 4Q profit falls 12 pct, hurt by patent loss Washington Examiner · January 30, 2014 12:45 pm
Business Stocks rise on Wall Street after 3 days of losses Steve Rothwell · January 28, 2014 10:31 pm
Healthcare FDA bureaucracy stifles access to life-saving drugs Erik Telford · January 23, 2014 5:00 am
Healthcare FDA panel again rejects wider use of J&J’s Xarelto Washington Examiner · January 16, 2014 9:38 pm
Op-Eds Grandstanding AGs sue to stop drugmaker’s work to insure patients take medicine properly Peter Pitts · January 14, 2014 5:00 am
Op-Eds FDA must decide if a biosimilar rose by any other name is still a rose Peter Pitts · December 9, 2013 5:00 am
Columnists Big Pharma, not tobacco companies, wages war on electronic cigarettes Timothy P. Carney · November 19, 2013 5:00 am
Columnists If Big Pharma likes your healthcare plan, you can keep it Timothy P. Carney · November 1, 2013 4:00 am
Beltway Confidential Drug Industry Briefing: 52,500 bought insurance on state exchanges Timothy P. Carney · October 31, 2013 4:00 am
Beltway Confidential How industry captures regulatory agencies: drugmakers and the FDA Timothy P. Carney · October 7, 2013 4:00 am
Business
